When did OrthoPediatrics report Q4 2024 earnings?

OrthoPediatrics (KIDS) reported Q4 2024 earnings on March 4, 2025 after market close.

What were OrthoPediatrics's Q4 2024 revenue and EPS?

OrthoPediatrics reported revenue of $52.7M and eps of $-0.29 for Q4 2024.

Did OrthoPediatrics beat estimates in Q4 2024?

Revenue missed the consensus estimate of $53.0M by $317.0K. EPS beat the consensus estimate of $-0.33 by $0.04.

Where can I find OrthoPediatrics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001425450-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.

OrthoPediatrics KIDS Q4 2024 Annual earnings

Reported March 4, 2025 · After market close

Revenue$52.7MMiss by $317.0K

EPS-$0.29Beat by $0.04

Revenue estimate$53.0M

EPS estimate-$0.33

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$68.2M

EPS estimate-$0.31

Financials

Q4 2024

Income statement

See full

Revenue$52.7M+40.0%

Gross profit$35.6M+33.1%

Operating income-$14.1M-74.2%

Net income-$16.1M-140%

EPS (diluted)-$0.70-141%

Balance sheet

See full

Cash & equivalents$45.8M+38.6%

Total debt$9.3M+708%

Total equity$354.6M-6.0%

Total assets$473.2M+7.9%

Cash flow

See full

Operating cash flow-$4.0M+47.1%

CapEx--100%

Free cash flow-$3.7M+67.3%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$561.33M-24.1%

Enterprise value$524.86M-25.9%

P/S2.7×-2.2×

Profitability

See full

Gross margin72.6%-2.2pp

Operating margin-17.1%-0.8pp

Net margin-18.5%+8.3pp

FCF margin-20.2%-4.9pp

Returns & leverage

See full

Return on equity-10.3%+64.9pp

Debt / equity0×0.0×

Current ratio7×+1.5×

Segments

By product

See full

Trauma and deformity$36.4M+34.5%

Scoliosis$15.6M+61.8%

Sports medicine/other$624.0K-29.4%

By geography

See full

U.S.$42.9M+51.8%

Versus estimates

Revenue

Q1 2026$59.4MBeat by $1.1M Q4 2025$61.6MBeat by $1.4M Q3 2025$61.3MBeat by $2.0M Q2 2025$61.1MMiss by $317.6K Q1 2025$52.4MBeat by $728.1K

Q4 2024$52.7MMiss by $317.0K

Diluted EPS

Q1 2026-$0.42Miss by $0.04 Q4 2025-$0.26Beat by $0.11 Q3 2025-$0.24Beat by $0.02 Q2 2025-$0.11Beat by $0.06 Q1 2025-$0.39Miss by $0.13

Q4 2024-$0.29Beat by $0.04

Ask the moment OrthoPediatrics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did OrthoPediatrics report Q4 2024 earnings?: OrthoPediatrics (KIDS) reported Q4 2024 earnings on March 4, 2025 after market close.
What were OrthoPediatrics's Q4 2024 revenue and EPS?: OrthoPediatrics reported revenue of $52.7M and eps of $-0.29 for Q4 2024.
Did OrthoPediatrics beat estimates in Q4 2024?: Revenue missed the consensus estimate of $53.0M by $317.0K. EPS beat the consensus estimate of $-0.33 by $0.04.
Where can I find OrthoPediatrics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001425450-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.